Abstract
Virtual screening and synthesis of novel pyrrolidine derivatives are proposed aiming pharmacological activity against the alpha 4 beta 2 nicotine acetylcholine receptors (nAChRs). The pharmacological evaluation will be performed in collaboration. (AU)